Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s15010-020-01557-7 http://scihub22266oqcxt.onion/10.1007/s15010-020-01557-7 33389708!7778417!33389708     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Infection 2021 ; 49 (3): 401-410 Nephropedia Template TP {{tp|p=33389708|t=2021. Remdesivir in Coronavirus Disease 2019 (COVID-19) treatment: a review of evidence |pdf=|usr=}}{{33389708}} gab.com Text Remdesivir in Coronavirus Disease 2019 (COVID-19) treatment: a review of evidence JO: Infection http://www.kidney.de/pget.php?&tw=1&pmid=33389708 #FOAvip COVID-19 is an infectious disease caused by a novel beta-coronavirus, belonging to the same subgenus as the Severe Acute Respiratory Syndrome (SARS) virus. Remdesivir, an investigational broad-spectrum antiviral agent has previously demonstrated in vitro activity against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), and in vivo efficacy against other related coronaviruses in animal models. Its safety profile has been tested in a compassionate use setting for patients with COVID-19. The current therapeutic studies demonstrate clinical effectiveness of remdesivir in COVID-19 patients by shortening time to clinical recovery, and hospital stay. In this review, we critically analyze the current evidence of remdesivir against COVID-19 and dissect the aspects over its safety and efficacy. Based on existing data, remdesivir can be regarded as a potential therapeutic agent against COVID-19. Further large-scale, randomized placebo-controlled clinical trials are, however, awaited to validate these findings. Twit Text FOAVip Remdesivir in Coronavirus Disease 2019 (COVID-19) treatment: a review of evidence ????Infection http://www.kidney.de/pget.php?&tw=1&pmid=33389708 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33389708 #FOAvip English Wikipedia <ref>{{Cite pmid|33389708}}</ref> Remdesivir in Coronavirus Disease 2019 (COVID-19) treatment: a review of evidence #MMPMID33389708 Lin HXJ; Cho S; Meyyur Aravamudan V; Sanda HY; Palraj R; Molton JS; Venkatachalam I Infection 2021[Jun]; 49 (3): 401-410 PMID33389708show ga COVID-19 is an infectious disease caused by a novel beta-coronavirus, belonging to the same subgenus as the Severe Acute Respiratory Syndrome (SARS) virus. Remdesivir, an investigational broad-spectrum antiviral agent has previously demonstrated in vitro activity against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), and in vivo efficacy against other related coronaviruses in animal models. Its safety profile has been tested in a compassionate use setting for patients with COVID-19. The current therapeutic studies demonstrate clinical effectiveness of remdesivir in COVID-19 patients by shortening time to clinical recovery, and hospital stay. In this review, we critically analyze the current evidence of remdesivir against COVID-19 and dissect the aspects over its safety and efficacy. Based on existing data, remdesivir can be regarded as a potential therapeutic agent against COVID-19. Further large-scale, randomized placebo-controlled clinical trials are, however, awaited to validate these findings. |*COVID-19 Drug Treatment[MESH] |Adenosine Monophosphate/*analogs & derivatives/therapeutic use[MESH] |Alanine/*analogs & derivatives/therapeutic use[MESH] |Animals[MESH] |Antiviral Agents/*therapeutic use[MESH] |COVID-19/epidemiology[MESH] |Humans[MESH] |SARS-CoV-2/drug effects[MESH] |Time Factors[MESH]Remdesivir in Coronavirus Disease 2019 (COVID-19) treatment: a review (epmc).pdf DeepDyve Pubget Overpricing